LABCORP HOLDINGS INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
LABCORP HOLDINGS INC. (LH) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $728.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-24
- LABCORP HOLDINGS INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2016-03-31 was $914.00M, a 54.00% increase year-over-year.
- LABCORP HOLDINGS INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2015-03-31 was $593.50M, a 21.13% decline year-over-year.
- LABCORP HOLDINGS INC. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2014-03-31 was $752.50M.
- LABCORP HOLDINGS INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $728.90M, a 15.75% increase from fiscal 2024.
- LABCORP HOLDINGS INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $629.70M, a 24.94% increase from fiscal 2023.
- LABCORP HOLDINGS INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $504.00M, a 54.09% decline from fiscal 2022.
- LABCORP HOLDINGS INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $1.10B, a 55.28% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $728.90M 10-K · filed 2026-02-24 | ||
| 2024-12-31 | $629.70M 10-K · filed 2026-02-24 | ||
| 2023-12-31 | $504.00M 10-K · filed 2026-02-24 | ||
| 2022-12-31 | $1.10B 10-K · filed 2025-02-25 | $1.32B 10-K · filed 2023-02-28 | |
| 2021-12-31 | $2.46B 10-K · filed 2024-02-26 | $2.58B 10-K · filed 2022-02-25 | |
| 2020-12-31 | $1.85B 10-K · filed 2023-02-28 | ||
| 2019-12-31 | $784.40M 10-K · filed 2022-02-25 | ||
| 2018-12-31 | $937.70M 10-K · filed 2021-02-25 | ||
| 2017-12-31 | $838.80M 10-K · filed 2020-02-28 | $891.80M 10-K · filed 2018-02-27 | |
| 2016-12-31 | $884.50M 10-K · filed 2019-02-28 | $914.00M 10-K · filed 2017-02-27 | |
| 2016-03-31 | $914.00M 10-K · filed 2018-02-27 | ||
| 2015-12-31 | $593.50M 10-K · filed 2017-02-27 | $599.60M 10-K · filed 2016-02-29 | |
| 2015-03-31 | $593.50M 10-K · filed 2018-02-27 | ||
| 2014-12-31 | $758.60M 10-K · filed 2016-03-01 | ||
| 2014-03-31 | $752.50M 10-K · filed 2017-02-27 | ||
| 2013-12-31 | $844.20M 10-K · filed 2016-03-01 | ||
| 2012-12-31 | $909.00M 10-K · filed 2015-02-26 | ||
| 2011-12-31 | $834.00M 10-K · filed 2014-02-25 | ||
| 2010-12-31 | $876.10M 10-K · filed 2013-02-26 | ||
| 2009-12-31 | $848.00M 10-K · filed 2012-02-24 | ||
| 2008-12-31 | $747.80M 10-K/A · filed 2011-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |